AIM:To explore the feasibility of performing minimally invasive surgery(MIS) on subsets of submucosal gastric cancers that are unlikely to have regional lymph node metastasis.METHOPS:A total of 105 patients underwent ...AIM:To explore the feasibility of performing minimally invasive surgery(MIS) on subsets of submucosal gastric cancers that are unlikely to have regional lymph node metastasis.METHOPS:A total of 105 patients underwent radical gastrectomy with lymph node dissection for submucosal gastric cancer at our hospital from January 1995 to December 1995,Besides investigating many clinicopathological features such as tumor size,gross appearance,and differentiation,we measured the depth of invasion into submucosa minutely and analyzed the clinicopathologic features of these patients regarding lymph node metastasis.RESULTS:the rate of lymph node metastasis in cases where the depth of invasion was<500μm,500-200μm,or>2000μm was 9% (2/23),19%(7/36),and 33%(15/46),respectively(P<0.05).In univariate analysis,no significant correlation was found between lymph node metastasis and clinicopathological characteristics such as age,sex,tumor location,gross appearance,tumor differentiation,Lauren's classification,and lymphatic invasion,In multivariate analysis,tumor size(>4cm vs≤2cm,odds ratio=4。80,P=0.04)and depth of invasion(>2000μm vs ≤500μm,odds ratio=6.81,P=0.02)were significantly correlated with lymph node metastasis,Combining the depth and size in cases where the depth of invasion was less than 500μm,we found that lymph node metastasis occurred where the tumor size was greater than 4 cm.In cases where the tumor size was less than 2 cm,lymph node metastasis was found only where the depth of tumor invasion was more than 2000μm.CONCLUSION:MIS can be applied to submucosal gastric cancer that is less than 2 cm in size and 500μm in depth.展开更多
Laparoscopic gastrectomy has been widely accepted as a standard alternative for the treatment of early-stage gastric adenocarcinoma because of its favorable shortterm outcomes. Although controversies exist, such as es...Laparoscopic gastrectomy has been widely accepted as a standard alternative for the treatment of early-stage gastric adenocarcinoma because of its favorable shortterm outcomes. Although controversies exist, such as establishing clear indications, proper preoperative staging, and oncologic safety, experienced surgeons and institutions have applied this approach, along with various types of function-preserving surgery, for the treatment of advanced gastric cancer. With technical advancement and the advent of state-of-the-art instruments, indications for laparoscopic gastrectomy are expected to expand as far as locally advanced gastric cancer. Laparoscopic gastrectomy appears to be promising; however, scientific evidence necessary to generalize this approach to a standard treatment for all relevant patients and care providers remains to be gathered. Several multicenter, prospective randomized trials in high-incidence countries are ongoing, and results from these trials will highlight the short- and long-term outcomes of the approach. In this review, we describe up-to-date findings and critical issues regarding laparoscopic gastrectomy for gastric cancer.展开更多
目的观察"重建中气"中药复方对进展期胃癌术后及辅助化学治疗后患者生存期的影响。方法回顾分析62例进展期胃癌患者的临床资料,根据是否服用"重建中气"中药复方将其分为中药暴露、无中药暴露两个队列。中药暴露组以...目的观察"重建中气"中药复方对进展期胃癌术后及辅助化学治疗后患者生存期的影响。方法回顾分析62例进展期胃癌患者的临床资料,根据是否服用"重建中气"中药复方将其分为中药暴露、无中药暴露两个队列。中药暴露组以"香砂六君子汤"为主方辨证加减。观察性别、年龄、首次就诊体质量和体质量指数(body mass index,BMI)、卡氏功能状态(Karnorfsky performance status,KPS)评分、复发或转移、中药暴露等因素对进展期胃癌生存期的影响。结果对62例患者随访2年,与无中药暴露组比较,中药暴露组患者体质量和BMI显著升高(P<0.05),复发或转移率显著降低(P<0.05);Kaplan-Meier单因素生存分析结果显示,中药暴露、基线KPS评分、复发或转移、基线BMI是生存期的影响因素(P<0.05);COX多因素回归分析显示,KPS评分是总生存期的独立影响因素。结论进展期胃癌术后患者为口服中药的优势人群,"重建中气"中药复方可增加或稳定进展期胃癌患者的体质量,提高患者生存质量,改善预后生存。展开更多
文摘AIM:To explore the feasibility of performing minimally invasive surgery(MIS) on subsets of submucosal gastric cancers that are unlikely to have regional lymph node metastasis.METHOPS:A total of 105 patients underwent radical gastrectomy with lymph node dissection for submucosal gastric cancer at our hospital from January 1995 to December 1995,Besides investigating many clinicopathological features such as tumor size,gross appearance,and differentiation,we measured the depth of invasion into submucosa minutely and analyzed the clinicopathologic features of these patients regarding lymph node metastasis.RESULTS:the rate of lymph node metastasis in cases where the depth of invasion was<500μm,500-200μm,or>2000μm was 9% (2/23),19%(7/36),and 33%(15/46),respectively(P<0.05).In univariate analysis,no significant correlation was found between lymph node metastasis and clinicopathological characteristics such as age,sex,tumor location,gross appearance,tumor differentiation,Lauren's classification,and lymphatic invasion,In multivariate analysis,tumor size(>4cm vs≤2cm,odds ratio=4。80,P=0.04)and depth of invasion(>2000μm vs ≤500μm,odds ratio=6.81,P=0.02)were significantly correlated with lymph node metastasis,Combining the depth and size in cases where the depth of invasion was less than 500μm,we found that lymph node metastasis occurred where the tumor size was greater than 4 cm.In cases where the tumor size was less than 2 cm,lymph node metastasis was found only where the depth of tumor invasion was more than 2000μm.CONCLUSION:MIS can be applied to submucosal gastric cancer that is less than 2 cm in size and 500μm in depth.
基金Supported by ETRI R&D Program(14ZC1400The Development of a Realistic Surgery Rehearsal System based on Patient Specific Surgical Planning)funded by the Government of South Korea
文摘Laparoscopic gastrectomy has been widely accepted as a standard alternative for the treatment of early-stage gastric adenocarcinoma because of its favorable shortterm outcomes. Although controversies exist, such as establishing clear indications, proper preoperative staging, and oncologic safety, experienced surgeons and institutions have applied this approach, along with various types of function-preserving surgery, for the treatment of advanced gastric cancer. With technical advancement and the advent of state-of-the-art instruments, indications for laparoscopic gastrectomy are expected to expand as far as locally advanced gastric cancer. Laparoscopic gastrectomy appears to be promising; however, scientific evidence necessary to generalize this approach to a standard treatment for all relevant patients and care providers remains to be gathered. Several multicenter, prospective randomized trials in high-incidence countries are ongoing, and results from these trials will highlight the short- and long-term outcomes of the approach. In this review, we describe up-to-date findings and critical issues regarding laparoscopic gastrectomy for gastric cancer.
文摘目的观察"重建中气"中药复方对进展期胃癌术后及辅助化学治疗后患者生存期的影响。方法回顾分析62例进展期胃癌患者的临床资料,根据是否服用"重建中气"中药复方将其分为中药暴露、无中药暴露两个队列。中药暴露组以"香砂六君子汤"为主方辨证加减。观察性别、年龄、首次就诊体质量和体质量指数(body mass index,BMI)、卡氏功能状态(Karnorfsky performance status,KPS)评分、复发或转移、中药暴露等因素对进展期胃癌生存期的影响。结果对62例患者随访2年,与无中药暴露组比较,中药暴露组患者体质量和BMI显著升高(P<0.05),复发或转移率显著降低(P<0.05);Kaplan-Meier单因素生存分析结果显示,中药暴露、基线KPS评分、复发或转移、基线BMI是生存期的影响因素(P<0.05);COX多因素回归分析显示,KPS评分是总生存期的独立影响因素。结论进展期胃癌术后患者为口服中药的优势人群,"重建中气"中药复方可增加或稳定进展期胃癌患者的体质量,提高患者生存质量,改善预后生存。